Andrew Krivoshik

Andrew Krivoshik

UNVERIFIED PROFILE

Are you Andrew Krivoshik?   Register this Author

Register author
Andrew Krivoshik

Andrew Krivoshik

Publications by authors named "Andrew Krivoshik"

Are you Andrew Krivoshik?   Register this Author

25Publications

981Reads

26Profile Views

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.

N Engl J Med 2018 Jun;378(26):2465-2474

From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) - both in Illinois; Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.); Herlev Hospital, Herlev, Denmark (P.R.); Carolina Urologic Research Center, Myrtle Beach, SC (N.S.); State University of Campinas (Unicamp), Campinas, Brazil (U.F.); Kiev City Clinical Hospital 3, Kiev, Ukraine (P.I.); Pfizer, San Francisco (E.D., K.M.); and the Department of Medical Oncology, San Camillo Forlanini Hospital, Rome (C.N.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1800536DOI Listing
June 2018

Clinical Outcomes of Chemotherapy Naïve Men with Metastatic Castration Resistant Prostate Cancer and Low Baseline Prostate Specific Antigen Treated with Enzalutamide vs Placebo.

J Urol 2017 12 20;198(6):1324-1332. Epub 2017 Jul 20.

Oregon Health & Science University Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.07.071DOI Listing
December 2017

Risk Factors for and Incidence of Seizures in Metastatic Castration-Resistant Prostate Cancer: A Real-World Retrospective Cohort Study.

Clin Drug Investig 2017 Dec;37(12):1183-1190

Astellas Pharma, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40261-017-0578-0DOI Listing
December 2017

Reply to M.A.N. Şendur et al and J. Michels.

J Clin Oncol 2017 01 31;35(1):123. Epub 2016 Oct 31.

David F. Penson, Vanderbilt University and the VA Tennessee Valley Geriatric Research, Education, and Clinical Center, Nashville, TN; Andrew J. Armstrong, Duke University, Durham, NC; Raoul Concepcion, Urology Associates PC, Nashville, TN; Neeraj Agarwal, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, Netherlands; and Celestia S. Higano, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.69.9371DOI Listing
January 2017

Enzalutamide Versus Bicalutamide in Castration-Resistant Prostate Cancer: The STRIVE Trial.

J Clin Oncol 2016 06 25;34(18):2098-106. Epub 2016 Jan 25.

David F. Penson, Vanderbilt University Medical Center and Tennessee Valley Veterans Administration Medical Center Geriatric Research, Education, and Clinical Center; Raoul Concepcion, Urology Associates PC, Nashville, TN; Andrew J. Armstrong, Duke Cancer Institute, Duke University, Durham, NC; Neeraj Agarwal, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT; Carl Olsson, Icahn School of Medicine at Mount Sinai, New York, NY; Lawrence Karsh, The Urology Center of Colorado, Denver, CO; Curtis Dunshee, Urological Associates of Southern Arizona, Tucson, AZ; Fong Wang and Kenneth Wu, Medivation, San Francisco, CA; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; De Phung, Astellas Pharma Global Development, Leiden, The Netherlands; and Celestia S. Higano, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.9285DOI Listing
June 2016

Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.

J Clin Oncol 2013 Oct 9;31(30):3791-9. Epub 2013 Sep 9.

Robert J. Motzer, Memorial Sloan-Kettering Cancer Center, New York, NY; Dmitry Nosov, N.N. Blokhin Cancer Research Center; Boris Y. Alekseev, Federal State Institution, Moscow Research Oncological Institute, Moscow; Oleg Lipatov, State Budget Medical Institution, Republican Clinical Oncological Center, Bashkortostan; Anna Alyasova, Federal Budget Medical Institution, Privolzhsky District Medical Center, Nizhny Novgorod; Mikhail Kogan, State Budget Higher Educational Institute, The Rostov State Medical University, Rostov-on-Don, Russia; Timothy Eisen, Cambridge University Health Partners, Cambridge, United Kingdom; Igor Bondarenko, Dnipropetrovsk State Medical Academy under the Ministry of Health of Ukraine, Dnipropetrovsk; Vladimir Lesovoy, V.I. Shapoval Regional Clinical Center for Urology and Nephrology, Kharkiv; Oleksiy Lyulko, Zaporizhia Medical Academy of Postgraduate Education, Zaporizhia, Ukraine; Piotr Tomczak, Clinical Hospital No. 1 of the Poznan University of Medical Sciences, Poznań; Cezary Szczylik, Military Institute of Health, Warsaw, Poland; Mihai Harza, Fundeni Clinical Institute, Bucharest, Romania; Cora N. Sternberg, San Camillo and Forlanini Hospitals, Rome, Italy; David Cella, Northwestern University Feinberg School of Medicine, Chicago; Andrew Krivoshik, Astellas Pharma Global Development, Northbrook, IL; Cristina Ivanescu, Quintiles, Hoofddorp, the Netherlands; Brooke Esteves, Anna Berkenblit, Andrew Strahs, AVEO Oncology, Cambridge, MA; Thomas E. Hutson, Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.47.4940DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569677PMC
October 2013

Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.

J Clin Oncol 2011 Mar 7;29(8):1075-82. Epub 2011 Feb 7.

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, David H. Koch Cancer Research Building 2, 1550 Orleans St, Rm 544, Baltimore, MD 21231, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.32.5944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4672026PMC
March 2011

Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors.

Cancer Chemother Pharmacol 2010 Sep 1;66(4):737-43. Epub 2010 Jan 1.

Pediatric Oncology Branch, National Cancer Institute, 10 Center Drive, Bethesda, MD 20892-1101, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1218-zDOI Listing
September 2010